Stock SGTI SHENGTAI PHARMACEUTICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Shengtai Pharmaceutical, Inc.

Equities

SGTI

US8232142005

Market Closed - OTC Markets
Other stock markets
 06:40:00 12/12/2023 am IST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Shengtai Pharmaceutical, Inc. -.--% -.--%
2013 Qingtai Liu, Chairman and Chief Executive Officer of Shengtai Pharmaceutical Inc. cancelled the acquisition of the remaining 59.5% stake in Shengtai Pharmaceutical Inc. from Pope Investments LLC, a fund of Pope Asset Management, LLC and other investors. CI
2013 Shengtai Pharmaceutical Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2013 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Qingtai Liu, Chairman and Chief Executive Officer of Shengtai Pharmaceutical Inc. cancelled the acquisition of the remaining 59.5% stake in Shengtai Pharmaceutical Inc. from Pope Investments LLC, a fund of Pope Asset Management, LLC and other investors.
CI
Shengtai Pharmaceutical Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2013
CI
Shengtai Pharmaceutical Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2012
CI
Shengtai Pharmaceutical Inc. Announces Unaudited Consolidated Financial Results for the First Quarter Ended September 30, 2012
CI
Shengtai Pharmaceutical Inc. Announces Consolidated Earnings Results for the Year Ended June 30, 2012
CI
Shengtai Pharmaceutical Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2012
CI
Qingtai Liu, Chairman and Chief Executive Officer of Shengtai Pharmaceutical Inc. made an offer to acquire remaining 59.5% stake in Shengtai Pharmaceutical Inc. from Pope Investments LLC, a fund of Pope Asset Management, LLC and other investors for $9.4 million.
CI
Shengtai Pharmaceutical Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2011
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SGTI Stock
  4. News Shengtai Pharmaceutical, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW